🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

For all the scientists who have spent way too long creating posters in PPT at 4000% zoom...🔎😭 We're so excited to announce Poster Builder! ✨ Drag and drop sections, dynamically resize columns & rows, change color themes and more! Try it free: app.biorender.com/#new-poster

Thanks for sharing! Check out our latest work which focuses on NOX2 activity in PD, the downstream effects of elevated NOX2 and how it might contribute to pathogenesis. Huge thank you to all of the co-authors who helped out with this study. Excited to continue to learn more

A small molecule inhibitor of #LRRK2 shows promise against #ParkinsonsDisease in animals and proves safe for patients in a phase 1 trial, shows new research in Science Translational Medicine. fcld.ly/1m0hemg

Thank you @AaronJ_PhD_IP for giving us the opportunity to talk about some of our most recent work!

Get ready.... The 2022 Molecular Pharmacology retreat is this Thursday at Phipps Conservatory! 🌺🌻🪷🌹🌸

Thanks to everyone who came out to celebrate with us. Together we raised, $4 million to bring an end to #Parkinsons. Visit our website for more highlights: bit.ly/3Fvxm58

Congratulations Tim! You have been such a fantastic mentor and have taught me so much. Grateful for all that you have done for me and honored to be a part of your scientific family. Well deserved!

Big congratulations to MPGP student @AngeHinchie on her co-authorship in SCIENCE! science.org/doi/10.1126/sc…

I wrote an article! With lots of help from my great science writing mentors of course. Allison M. Hydzik @AsherGJones Congratulations to Dr. Alder, Pattra, @AngeHinchie and all of the authors. What a fantastic story!

Interesting - University of Pittsburgh researchers report on the in vitro & in vivo neuroprotective actions of a fatty acid nitroalkene in models of #Parkinsons; It activated Nrf2-regulated gene expression & inhibited NOX2 & LRRK2 hyperactivation nature.com/articles/s4153…

A twist of fate indeed Tim is an amazing researcher who has been instrumental in #Parkinsons research in many different ways. This is a hard, but also amazing story to read science.org/content/articl…

Interesting: New research from Vik Khurana Lab & colleagues presents a toolbox for "screenable iPSC 'inclusionopathy' models utilizing piggyBac or targeted transgenes to rapidly induce CNS cells that express aggregation-prone proteins at brain-like levels" cell.com/neuron/fulltex…

Studying the mechanistic action of pesticides within humans is difficult. Dr. Briana De Miranda shares how these products are studied within the lab and how they influence the development of Parkinson’s disease. Tiago Outeiro @bdemiranda loom.ly/M3RKMlY

The new issue of #ScienceTranslationalMedicine is out now! scim.ag/8oI

Thank you for sharing our latest work! Also, thank you to our collaborators for their help. None of this would’ve been possible without the support and guidance from my mentor, Tim Greenamyre

LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson’s disease | Science Translational Medicine science.org/doi/10.1126/sc…

Pitt's Tim Greenamyre joins NBC News to discuss his groundbreaking research into environmental factors related to Parkinson’s. Known as the "Parkinson's Belt," there are a series of regions in the U.S. with unusually high rates of the disease. nbcnews.com/now/video/scie…

New publication🧠 In the Greenamyre lab at Pitt Health Sciences, they study Parkinson’s disease and use Navinci’s isPLA assay regularly to decipher novel mechanisms that contribute to the disease. Read their latest paper: lnkd.in/dZnaR8Hn Matt Keeney Science Magazine

We are thrilled to announce that renowned physician-scientist J. Timothy Greenamyre, M.D., Ph.D., of University of Pittsburgh, will be the recipient of the 2025 Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research! vai.org/2025-jva-award